Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1972 1
1973 1
1974 2
1976 1
1977 3
1979 2
1980 6
1981 2
1982 5
1983 4
1984 4
1985 5
1986 6
1987 7
1988 9
1989 11
1990 7
1991 5
1992 16
1993 14
1994 11
1995 17
1996 20
1997 24
1998 18
1999 13
2000 22
2001 28
2002 17
2003 11
2004 20
2005 17
2006 21
2007 13
2008 17
2009 26
2010 23
2011 26
2012 17
2013 22
2014 21
2015 26
2016 32
2017 33
2018 30
2019 24
2020 25
2021 35
2022 33
2023 24

Text availability

Article attribute

Article type

Publication date

Search Results

724 results

Results by year

Filters applied: . Clear all
Page 1
Fibroblasts positive for meflin have anti-fibrotic properties in pulmonary fibrosis.
Nakahara Y, Hashimoto N, Sakamoto K, Enomoto A, Adams TS, Yokoi T, Omote N, Poli S, Ando A, Wakahara K, Suzuki A, Inoue M, Hara A, Mizutani Y, Imaizumi K, Kawabe T, Rosas IO, Takahashi M, Kaminski N, Hasegawa Y. Nakahara Y, et al. Eur Respir J. 2021 Dec 23;58(6):2003397. doi: 10.1183/13993003.03397-2020. Print 2021 Dec. Eur Respir J. 2021. PMID: 34049947 Free article.
First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in advanced non-small cell lung cancer: a subanalysis of Asian patients in CheckMate 9LA.
John T, Sakai H, Ikeda S, Cheng Y, Kasahara K, Sato Y, Nakahara Y, Takeda M, Kaneda H, Zhang H, Maemondo M, Minato K, Hisada T, Misumi Y, Satouchi M, Hotta K, Li A, Oukessou A, Lu S. John T, et al. Among authors: nakahara y. Int J Clin Oncol. 2022 Apr;27(4):695-706. doi: 10.1007/s10147-022-02120-0. Epub 2022 Feb 19. Int J Clin Oncol. 2022. PMID: 35182247 Free PMC article. Clinical Trial.
A Randomized Comparison of Nivolumab versus Nivolumab + Docetaxel for Previously Treated Advanced or Recurrent ICI-Naïve Non-Small Cell Lung Cancer: TORG1630.
Taniguchi Y, Shimokawa T, Takiguchi Y, Misumi T, Nakamura Y, Kawashima Y, Furuya N, Shiraishi Y, Harada T, Tanaka H, Miura S, Uchiyama A, Nakahara Y, Tokito T, Naoki K, Bessho A, Goto Y, Seike M, Okamoto H. Taniguchi Y, et al. Among authors: nakahara y. Clin Cancer Res. 2022 Oct 14;28(20):4402-4409. doi: 10.1158/1078-0432.CCR-22-1687. Clin Cancer Res. 2022. PMID: 35980349 Free PMC article. Clinical Trial.
Reply.
Nakahara Y, Kanemura T. Nakahara Y, et al. Ann Thorac Surg. 2018 Jul;106(1):311. doi: 10.1016/j.athoracsur.2018.03.031. Epub 2018 Apr 16. Ann Thorac Surg. 2018. PMID: 29673633 No abstract available.
Circulating MicroRNAs in Gastrointestinal Cancer.
Ohtsuka M, Iwamoto K, Naito A, Imasato M, Hyuga S, Nakahara Y, Mikamori M, Furukawa K, Moon J, Asaoka T, Kishi K, Shamma A, Akamatsu H, Mizushima T, Yamamoto H. Ohtsuka M, et al. Among authors: nakahara y. Cancers (Basel). 2021 Jul 3;13(13):3348. doi: 10.3390/cancers13133348. Cancers (Basel). 2021. PMID: 34283058 Free PMC article. Review.
Medical management of older patients with lung cancer.
Zenke Y, Hakozaki T, Nakahara Y, Horinouchi H, Ohe Y; Lung Cancer Study Group of the Japan Clinical Oncology Group (JCOG). Zenke Y, et al. Among authors: nakahara y. Jpn J Clin Oncol. 2022 Oct 6;52(10):1082-1088. doi: 10.1093/jjco/hyac135. Jpn J Clin Oncol. 2022. PMID: 35975674 Review.
Fluorescent sensing with nanoparticles.
Nakahara Y. Nakahara Y. Anal Sci. 2022 Nov;38(11):1369-1370. doi: 10.1007/s44211-022-00175-7. Anal Sci. 2022. PMID: 36274117 No abstract available.
724 results